Medindia

X

FDA Panel Recommends Against Approval of Drugs to Treat Hot Flashes

by Kathy Jones on  March 5, 2013 at 9:11 PM Drug News   - G J E 4
The US Food and Drug Administration has been advised to reject Noven Pharmaceuticals' drug for treating hot flashes in menopausal women.
 FDA Panel Recommends Against Approval of Drugs to Treat Hot Flashes
FDA Panel Recommends Against Approval of Drugs to Treat Hot Flashes
Advertisement

An advisory panel to the agency voted 10-4 against approval of the drug with many of the members saying that the benefits of the drug were not enough to outweigh the risks. The panel also voted 12-2 against approving another drug, Depomed's Sefelsa, for similar reasons and added that three clinical trials did not show any marked reduction in hot flashes in menopausal women.

Advertisement
Depomed's chief executive, Jim Schoeneck said that his company will stop spending on Sefelsa unless the hurdles for approving similar drugs are not overcome. "Based on today's meeting we believe the hurdles for approval of a nonhormonal treatment for hot flashes remain high. Until we believe there is a positive direction for Sefelsa, we will cease all spending relating to the product candidate", he said.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All